Anixa Biosciences Inc (ANIX) stock
ANIXNasdaqPharmaceutical PreparationsFiscal year ends October 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jul 31, 2026Last filing: 10-Q on Sep 9, 2026Score 6/30
$2.67+0.12 (+4.71%)
Close on Nov 17, 2026Market cap $92.82MP/E –Yield –
Anixa Biosciences gross margin
Gross margin is gross profit as a percentage of revenue.
For fiscal 2012 it was 99.6%, against 96.6% the year before.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2012 | Oct 31, 2012 | 99.6% | +3.0 |
| FY2011 | Oct 31, 2011 | 96.6% | +7.9 |
| FY2010 | Oct 31, 2010 | 88.7% | – |
See a number that looks wrong?